Retroviral vector of hFAS (CD95) and hCD25 (IL2R alpha).
![]() Drawn by SnapGene® software |
|
| Alternative name | CD95 and CD25 |
|---|---|
| Clone info. | Retroviral vector of hFAS (CD95) and hCD25 (IL2R alpha) as a surface marker. |
| Vector backbone | pRx (Plasmid) |
| Size of vector backbone | 5.5 kb |
| Selectable markers | Amp^r (E. coli) |
| Growth conditions | 37 C, LB+Amp |
| Gene/insert name | Human FAS (CD95) cDNA Human CD25 cDNA |
| Depositor|Developer | Hamada, Hirofumi | |
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
| Ordering forms | Order form [Credit Card Payment MTA, for use for not-for-profit academic purpose [Word Please visit Information of Request for Distribution.[link] |
|---|---|
| Terms and conditions for distribution | The availability of the BIOLOGICAL RESOURCE is limited to a RECIPIENT of a not-for profit institution for a not-for-profit research. RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature designated by the DEPOSITOR (J. Leukoc. Biol., 60, 181-190 (1996).) and an acknowledgment to the DEPOSITOR are requested. |
| Remarks | Remember that you will be working with samples containing infectious virus. |
[open/close]| 必要書類 | 提供依頼書 提供同意書 (MTA, 非営利学術目的用)[Word 手続きの概要は、「提供申込みについて[link]」をご覧ください。 |
|---|---|
| MTAに書く使用条件 | 非営利機関の非営利学術研究へ提供する。利用者が本件リソースを利用した研究成果に基づき特許申請、商業活動等を行う場合は、利用者は事前に寄託者に連絡する。利用者は、研究成果の公表にあたって寄託者の指定する文献 (J. Leukoc. Biol., 60, 181-190 (1996).) を引用し、謝辞の表明を必要とする。 |
| 備考 | このリソースはウイルス粒子産生用のため、取扱いに注意が必要です。 |
| Catalog # | Resource name | Shipping form | Fee |
|---|---|---|---|
| RDB01702 | pRx hFAS-i-hCD25 | DNA solution |
Materials & Methods section:
| The pRx hFAS-i-hCD25 was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB01702). |
Reference section:
Further references such as user reports and related articles (go to bottom)
Original, user report and related articles
| reference | Wakimoto, H., Efficient retrovirus-mediated cytokine-gene transduction of primary-cultured human glioma cells for tumor vaccination therapy. Jpn. J. Cancer Res., 88, 296-305 (1997). PMID 9140115. [PubMed] [Article] |
|---|---|
| user_report | Tone, Y., Death signalobody: inducing conditional cell death in response to a specific antigen. Hum. Gene Ther. Methods 24 (3):141-150 (2013). PMID 23470213. [PubMed] [Article] [RRC of NBRP] |
Featured content